好萊客(603898.SH):“好客轉債”將開始轉股 轉股價為16.62元/股
格隆匯2月7日丨好萊客(603898.SH)公佈,經上海證券交易所自律監管決定書﹝2019﹞181號同意,公司發行的6.3億元可轉換公司債券於2019年8月23日起在上海證券交易所上市交易,債券簡稱為“好客轉債”,債券代碼為“113542”。
根據有關規定和募集説明書的約定,公司此次發行的“好客轉債”的原轉股起始日為2020年2月7日,受疫情影響,復工延遲,故公司未能如期申請轉股,現將轉股起始日調整為2020年2月12日,對廣大債權持有人造成的影響深表歉意。
轉股價格為16.62元/股,轉股期起止日期為2020年2月12日至2025年7月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.